The Prevent Cancer Foundation, in partnership with ZERO Prostate Cancer, is proud to present the 2024 Prevent Cancer Dialogue on Updates in Early Detection: Prostate Cancer Screening. During this webinar, experts will discuss:
- Current prostate cancer screening trends and screening guidelines, including conflicting guidelines of different organizations
- Screening methods and their benefits and harms
- Advancements to address challenges, such as emerging innovations to help “screen smarter”
Speakers will also talk about the existing racial disparities in prostate cancer, their impact on health outcomes and the need for strategies to overcome them.
The importance of timely, regular screenings
Addressing this topic is vital, as prostate cancer is the most common cause of non-cutaneous cancer and the second leading cause of cancer death in men in the United States. Detecting early prostate cancer can save lives, but it's important to understand the benefits and risks of screening. Prostate cancer screening can lead to overdiagnosis (diagnosis of cancer that would have never led to problems) and overtreatment (treatment of cancers that would otherwise have never caused any problems). Because most prostate cancers are slow-growing, overtreatment can lead to long-term side effects or complications, including urinary incontinence and impotence.
According to the Prevent Cancer Foundation’s 2024 Early Detection Survey, 41 percent of Black or African American men of screening age say they are behind on their prostate cancer screening. The incidence of prostate cancer is more than 70 percent higher in Black men than in white men, for reasons that remain unclear. This is why it is especially important for Black men to stay on top of screenings and/or discuss recommended screenings with a healthcare provider.
Genetics can also play a role in prostate cancer diagnosis. About 10 percent of people with prostate cancer have a genetic mutation. Mutations in the BRCA1, BRCA2 and HOXB13 genes more commonly increase prostate cancer risk; however, mutations in other genes can also impact risk. Genetic testing may be an option for those who want more information about their cancer risk based on their family health history or race/ethnicity.
Expert speakers
The 90-minute Dialogue webinar will feature the following speakers:
- Sigrid Carlsson, MD, PhD, MPH, Memorial Sloan Kettering Cancer Center
- Kelvin Moses, MD, PhD, Vanderbilt University Medical Center
- Brian Bragg, MS, ZERO Prostate Cancer
Scheduled for September 11 at 1:00 p.m. ET, the webinar will provide the most up-to-date information on prostate cancer screening and will include moderated discussions with the audience. Continuing education credits will be offered, and registration is free, so register today to join the Dialogue!
Registration link: https://pcf.elevate.gocadmium.com
Prevent Cancer Foundation: https://www.preventcancer.org
The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Our mission is to empower people to stay ahead of cancer through prevention and early detection. Our vision is a world where cancer is preventable, detectable and beatable for all.